Benzinga · Aug 12, 2026
Talkspace And UHS Obtain All Required State Healthcare Approvals For Merger As Of Aug 11
-SEC Filing
TA
NASDAQ · TALK
Talkspace, Inc.
Healthcare · Medical - Care Facilities
$5.25
Up+$0.00 (+0.00%)
Updated Aug 22, 2026, 6:39 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 565.87M
- P/E ratio
- 133.8
- Dividend yield
- 0.00%
- 52-week range
- $2.49 – $5.25
- Volume
- 2.41M
- Avg. volume
- 1.37M
Price performance
TALK price history
1M range · 16 trading sessions · Daily adjusted prices
TALK closed at $5.25 after 16 trading sessions, up 0.77% for the selected period.
- Last close
- $5.25
- Period change
- +0.77%
- Period low
- $5.15
- Period high
- $5.25
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $5.25 | $5.25 | $5.24 | $5.25 | 2.41M |
| Aug 13, 2026 | $5.24 | $5.25 | $5.24 | $5.25 | 1.22M |
| Aug 12, 2026 | $5.24 | $5.25 | $5.24 | $5.24 | 1.44M |
| Aug 11, 2026 | $5.24 | $5.24 | $5.22 | $5.24 | 1.77M |
| Aug 10, 2026 | $5.22 | $5.24 | $5.22 | $5.24 | 847.27K |
| Aug 7, 2026 | $5.21 | $5.23 | $5.20 | $5.22 | 7.09M |
| Aug 6, 2026 | $5.21 | $5.23 | $5.21 | $5.21 | 661.49K |
| Aug 5, 2026 | $5.19 | $5.22 | $5.18 | $5.22 | 1.11M |
| Aug 4, 2026 | $5.22 | $5.22 | $5.15 | $5.15 | 3.6M |
| Aug 3, 2026 | $5.22 | $5.22 | $5.21 | $5.21 | 1.43M |
| Jul 31, 2026 | $5.23 | $5.23 | $5.21 | $5.22 | 1.77M |
| Jul 30, 2026 | $5.22 | $5.23 | $5.21 | $5.21 | 1.18M |
| Jul 29, 2026 | $5.22 | $5.23 | $5.22 | $5.22 | 786.27K |
| Jul 28, 2026 | $5.23 | $5.24 | $5.21 | $5.21 | 1.08M |
| Jul 27, 2026 | $5.22 | $5.23 | $5.21 | $5.22 | 672.5K |
| Jul 24, 2026 | $5.22 | $5.22 | $5.21 | $5.21 | 1.12M |
Latest TALK news
The latest Smart Investors Daily articles mentioning TALK.
Stock researchCompany · Overview
TALK research
Overview
Company profile and research snapshot.
Company profile
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $4.25
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 10, 2026 | Barclays | Equal-Weight | — |
| Mar 10, 2026 | Keybanc | Sector Weight | — |
| Mar 9, 2026 | Needham | Hold | — |
| Mar 9, 2026 | Canaccord Genuity | Hold | — |
| Feb 20, 2026 | TD Cowen | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Jun 9, 2026
Talkspace Announces ‘Tee,’ the First Safe AI Agent Specifically Developed to Help Individuals Navigate Life’s Daily Mental Health Challenges
NEW YORK, June 09, 2026--Talkspace (NASDAQ: TALK), a leading online behavioral healthcare provider, today announced Tee, a safe, fine-tuned large language model developed by mental health experts.
SeekingAlpha · Feb 21, 2026
Talkspace: Time To Shine As Profitability Takes Off
Benzinga · Feb 20, 2026
TD Cowen Maintains Buy on Talkspace, Raises Price Target to $9
TD Cowen analyst Charles Rhyee maintains Talkspace (NASDAQ:TALK) with a Buy and raises the price target from $6 to $9.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
